Joel Daouk
Overview
Explore the profile of Joel Daouk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blind S, Lerouge L, Gries M, Retif P, Thomas N, Barberi-Heyob M, et al.
Comput Biol Med
. 2025 Feb;
188:109861.
PMID: 39970825
Background And Objectives: The use of numerical models to predict radiosensitizing properties induced by metal-based nanoparticles (NPs) remains a real challenge in oncology. As most of the interactions due to...
2.
Dhaini B, Arnoux P, Daouk J, Lux F, Tillement O, Hagege A, et al.
Pharmaceuticals (Basel)
. 2024 Aug;
17(8).
PMID: 39204138
Photodynamic therapy is an accepted therapy cancer treatment. Its advantages encourage researchers to delve deeper. The use of nanoparticles in PDT has several advantages including the passive targeting of cancer...
3.
Schneller P, Collet C, Been Q, Rocchi P, Lux F, Tillement O, et al.
Pharmaceuticals (Basel)
. 2023 Jun;
16(2).
PMID: 37259295
Cerenkov-induced photodynamic therapy (CR-PDT) with the use of Gallium-68 (Ga) as an unsealed radioactive source has been proposed as an alternative strategy to X-ray-induced photodynamic therapy (X-PDT). This new strategy...
4.
Lerouge L, Gries M, Chateau A, Daouk J, Lux F, Rocchi P, et al.
Pharmaceutics
. 2023 Mar;
15(3).
PMID: 36986856
Glioblastoma (GBM) is the most difficult brain cancer to treat, and photodynamic therapy (PDT) is emerging as a complementary approach to improve tumor eradication. Neuropilin-1 (NRP-1) protein expression plays a...
5.
Douyere M, Gong C, Richard M, Pellegrini-Moise N, Daouk J, Pierson J, et al.
Cancer Cell Int
. 2022 Dec;
22(1):377.
PMID: 36457009
Background: Medulloblastoma (MB) is the most common pediatric malignant brain tumor. Despite current therapies, the morbidity and recurrent risk remains significant. Neuropilin-1 receptor (NRP1) has been implicated in the tumor...
6.
Dhaini B, Wagner L, Moinard M, Daouk J, Arnoux P, Schohn H, et al.
Pharmaceuticals (Basel)
. 2022 Sep;
15(9).
PMID: 36145315
Rose Bengal (RB) is a photosensitizer (PS) used in anti-cancer and anti-bacterial photodynamic therapy (PDT). The specific excitation of this PS allows the production of singlet oxygen and oxygen reactive...
7.
Daouk J, Iltis M, Dhaini B, Bechet D, Arnoux P, Rocchi P, et al.
Pharmaceuticals (Basel)
. 2021 Apr;
14(5).
PMID: 33922073
X-ray-induced photodynamic therapy is based on the energy transfer from a nanoscintillator to a photosensitizer molecule, whose activation leads to singlet oxygen and radical species generation, triggering cancer cells to...
8.
Gries M, Thomas N, Daouk J, Rocchi P, Choulier L, Jubreaux J, et al.
Int J Nanomedicine
. 2020 Nov;
15:8739-8758.
PMID: 33223826
Background: Local recurrences of glioblastoma (GBM) after heavy standard treatments remain frequent and lead to a poor prognostic. Major challenges are the infiltrative part of the tumor tissue which is...
9.
Promelle V, Bouzerar R, Daouk J, Iscar C, Milazzo S, Baledent O
J Glaucoma
. 2020 Sep;
30(1):65-70.
PMID: 32969916
Precis: Ophthalmic artery (OA) and superior ophthalmic vein (SOV) blood flow were quantified by phase contrast magnetic resonance imaging (PC MRI) and seemed lower in glaucoma. Venous flow dynamics was...
10.
Amouroux M, Salleron J, Huin-Schohn C, Ali S, Berthaud S, Rizo P, et al.
J Opt Soc Am A Opt Image Sci Vis
. 2019 Dec;
36(11):C62-C68.
PMID: 31873695
The current clinical study is aimed at evaluating the clinical relevance of an innovative device (called CyPaM2 device) that for the first time provides urologists with (i) a panoramic image...